Despite these benefits, the specific requirements for reimbursement have sparked criticism among specialists
No official dosing advice has been provided, however, doses of 500 2000 mg per day are typically used
In conclusion, whatever medication that increases endogenous portal insulin (signaling) in T2DM patients, regardless of the glucose level (specifically sulfonylurea derivatives and peroxisome proliferatoractivated receptor [PPAR-] agonists, but not dipeptidyl peptidase-4 inhibitor [DPP4i], or glucagonlike peptide-1 [GLP-1] analogues) will lead to an increase in body weight, even when caloric intake is not increased
Heavy drinking and binge drinking appear to be most likely to contribute to weight gain while light to moderate intake does not appear to be related
While all three medications operate on the same principle, there are differences between them